137 related articles for article (PubMed ID: 19057979)
1. Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome.
Shirai S; Yasuda T; Tsuchida H; Kuboshima S; Konno Y; Shima Y; Sato T; Hatta S; Masuhara K; Kimura K
Clin Exp Nephrol; 2009 Apr; 13(2):123-129. PubMed ID: 19057979
[TBL] [Abstract][Full Text] [Related]
2. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
[TBL] [Abstract][Full Text] [Related]
3. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
[TBL] [Abstract][Full Text] [Related]
4. Preprandial vs. postprandial pharmacokinetics of cyclosporine in patients with psoriasis.
Umezawa Y; Mabuchi T; Ozawa A
Int J Dermatol; 2007 Aug; 46(8):880-2. PubMed ID: 17651179
[TBL] [Abstract][Full Text] [Related]
5. More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome.
Kusaba T; Konno Y; Hatta S; Fujino T; Yasuda T; Miura H; Sasaki H; Okabayashi J; Murao M; Sakurada T; Imai G; Shirai S; Kuboshima S; Shima Y; Ogimoto G; Sato T; Masuhara K; Kimura K
Pharmacotherapy; 2005 Jan; 25(1):52-8. PubMed ID: 15767220
[TBL] [Abstract][Full Text] [Related]
6. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Shuto H; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
[TBL] [Abstract][Full Text] [Related]
7. Patients with adult minimal change nephrotic syndrome treated with long-term cyclosporine did not experience a reduction in their eGFR.
Inoue M; Yumura W; Morishita Y; Ito C; Hamano Y; Ando Y; Muto S; Kusano E
Clin Nephrol; 2013 Feb; 79(2):101-6. PubMed ID: 22948120
[TBL] [Abstract][Full Text] [Related]
8. Age effect on whole blood cyclosporine concentrations following oral administration in children with nephrotic syndrome.
Ushijima K; Uemura O; Yamada T
Eur J Pediatr; 2012 Apr; 171(4):663-8. PubMed ID: 22116269
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
Schädeli F; Marti HP; Frey FJ; Uehlinger DE
Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporin used de novo after renal transplantation.
Amante AJ; Meier-Kriesche HU; Schoenberg L; Kahan BD
Transpl Int; 1997; 10(3):217-22. PubMed ID: 9163863
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure.
Sugioka N; Fujimoto K; Tanaka Y; Fukushima K; Ito Y; Kokuhu T; Okamoto M; Yoshimura N; Takada K
Drug Metab Lett; 2009 Aug; 3(3):152-61. PubMed ID: 19702545
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome.
Naito M; Takei T; Eguchi A; Uchida K; Tsuchiya K; Nitta K
Intern Med; 2008; 47(18):1567-72. PubMed ID: 18797114
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome.
Kim JH; Park SJ; Yoon SJ; Lim BJ; Jeong HJ; Lee JS; Kim PK; Shin JI
J Clin Pathol; 2011 Jun; 64(6):516-9. PubMed ID: 21441261
[TBL] [Abstract][Full Text] [Related]
14. The impact of (1:1) cyclosporine A conversion to its microemulsion formulation on the kidney function of patients with cardiac allografts.
Khajehdehi P; Yip D; Bastani B
Clin Transplant; 1999 Apr; 13(2):176-80. PubMed ID: 10202614
[TBL] [Abstract][Full Text] [Related]
15. Retrospective single-arm cohort study of steroid-dependent minimal change nephrotic syndrome treated with very low-dose rituximab.
Fujimoto K; Kagaya Y; Kumano S; Fujii A; Tsuruyama Y; Matsuura T; Yamazaki K; Nomura K; Okada K; Okino K; Adachi H; Furuichi K; Yokoyama H
Clin Nephrol; 2021 Jan; 95(1):29-36. PubMed ID: 33074094
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A absorption profiles in children with nephrotic syndrome.
Nozu K; Iijima K; Sakaeda T; Okumura K; Nakanishi K; Yoshikawa N; Honda M; Ikeda M; Matsuo M
Pediatr Nephrol; 2005 Jul; 20(7):910-3. PubMed ID: 15856324
[TBL] [Abstract][Full Text] [Related]
17. Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome.
Woo KT; Chew ST; Vathsala A; Chiang GS
Ann Acad Med Singap; 2001 Jul; 30(4):430-5. PubMed ID: 11503553
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
Erkko P; Granlund H; Nuutinen M; Reitamo S
Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
[TBL] [Abstract][Full Text] [Related]
20. Pre- and postrenal transplantation pharmacokinetics of cyclosporine microemulsion.
Talaulikar GS; John GT; Selvakumar R; Job V; Thomas PP; Jacob CK
Transplant Proc; 2003 Jun; 35(4):1295-7. PubMed ID: 12826141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
